home All News open_in_new Full Article

Las píldoras, el nuevo objetivo de las 'farmas' para crecer en obesidad

Lilly y Novo Nordisk toman ventaja en la carrera por el lanzamiento de las pastillas para perder peso, pero compañías como Roche, Merck-MSD o AstraZeneca aceleran la investigación. Leer


today 8 d. ago attach_file Politics

attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics


ID: 1298749054
Add Watch Country

arrow_drop_down